HENRY IGID, MD
Hematology & Oncology Physician · LAS VEGAS, NV
Individual Active NPI 1003182106
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 706 | 268,307 | $18,762,614 | $5,088,213 | $4,059,334 |
| 2023 | 734 | 216,886 | $13,700,950 | $3,634,557 | $2,895,578 |
| 2022 | 704 | 253,054 | $17,313,990 | $4,860,781 | $3,872,511 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 32,640 | $0 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 17,100 | $0 | $0 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 13,870 | $0 | $0 |
| Q5101 | Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 13,380 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 11,700 | $49 | $39 |
| J9271 | Injection, pembrolizumab, 1 mg | 9,600 | $56 | $45 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 9,360 | $3 | $2 |
| J0897 | Injection, denosumab, 1 mg | 4,920 | $25 | $20 |
| J9267 | Injection, paclitaxel, 1 mg | 4,542 | $0 | $0 |
| J0185 | Injection, aprepitant, 1 mg | 3,380 | $2 | $1 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,771 | $0 | $0 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 1,580 | $1 | $1 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 17967 | NV |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Nevada
- NPI 1851603559
- NPI 1760738363
- NPI 1598790602
- NPI 1952374464
- NPI 1598770471
- NPI 1154984573
- NPI 1457745531
- NPI 1831557354
See all Hematology & Oncology Physician providers in Nevada →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.